MCO
80
2
MS
64
7
ALL
61
-2
STT
51
-5
O
31
3
PYPL
43
-4
FLS
56
-3
MAR
60
7
STZ
63
10
CMG
51
-3
MUR
50
-2
NRG
69
12
CAG
46
10
UAL
56
2
SLB
53
-3
ADI
59
-2
UA
32
8
BMY
56
3
PNW
66
3
IFF
56
-3
MCO
80
2
MS
64
7
ALL
61
-2
STT
51
-5
O
31
3
PYPL
43
-4
FLS
56
-3
MAR
60
7
STZ
63
10
CMG
51
-3
MUR
50
-2
NRG
69
12
CAG
46
10
UAL
56
2
SLB
53
-3
ADI
59
-2
UA
32
8
BMY
56
3
PNW
66
3
IFF
56
-3
Financhill
Back

SPDR® S&P Health Care Services ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
40

XHS
SPDR® S&P Health Care Services ETF

Last Price:
97.20
Seasonality Move:
0.35%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
40
SPDR® S&P Health Care Services ETF (XHS) is a Sell

Is SPDR® S&P Health Care Services ETF a Buy, Sell or Hold?

  • The current SPDR® S&P Health Care Services ETF [XHS] share price is $96.99. The Score for XHS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • XHS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

XHS Stock Price Chart

What is SPDR® S&P Health Care Services ETF's stock price today?

  • The SPDR® S&P Health Care Services ETF share price today is $96.99
    The current trend is moderately bullish and XHS is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

XHS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 50.58 Buy
Chaikin Money Flow: -1030 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (96.17 - 98.39) Sell
Bollinger Bands (100): (90.19 - 96.85) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

XHS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.28 Sell
20-day SMA: 97.46 Sell
50-day SMA: 96.45 Buy
200-day SMA: 91.4 Buy
8-day EMA: 97.35 Sell
20-day EMA: 97.1 Sell
50-day EMA: 95.97 Buy
200-day EMA: 92.17 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

SPDR® S&P Health Care Services ETF Earnings Growth & XHS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

SPDR® S&P Health Care Services ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):